| Polymorphisms of the DNA repair genes XRCC1 and XRCC3 and risk of lung and colorectal cancer: a case-control study in a Southern Italian population G Improta, A Sgambato, G Bianchino, A Zupa, V Grieco, G La Torre, ... Anticancer Research 28 (5B), 2941-2946, 2008 | 126 | 2008 |
| Biological and clinical relevance of miRNA expression signatures in primary plasma cell leukemia M Lionetti, P Musto, MT Di Martino, S Fabris, L Agnelli, K Todoerti, ... Clinical cancer research 19 (12), 3130-3142, 2013 | 103 | 2013 |
| Genome‐wide analysis of primary plasma cell leukemia identifies recurrent imbalances associated with changes in transcriptional profiles L Mosca, P Musto, K Todoerti, M Barbieri, L Agnelli, S Fabris, G Tuana, ... American journal of hematology 88 (1), 16-23, 2013 | 89 | 2013 |
| Positive effects on hematopoiesis in patients with myelodysplastic syndrome receiving deferasirox as oral iron chelation therapy: a brief review R Guariglia, MC Martorelli, O Villani, G Pietrantuono, G Mansueto, ... Leukemia research 35 (5), 566-570, 2011 | 80 | 2011 |
| Targeted inhibition of the epidermal growth factor receptor‐tyrosine kinase by ZD1839 (‘Iressa’) induces cell‐cycle arrest and inhibits proliferation in prostate cancer cells A Sgambato, A Camerini, B Faraglia, R Ardito, G Bianchino, D Spada, ... Journal of cellular physiology 201 (1), 97-105, 2004 | 75 | 2004 |
| Transcriptional characterization of a prospective series of primary plasma cell leukemia revealed signatures associated with tumor progression and poorer outcome K Todoerti, L Agnelli, S Fabris, M Lionetti, G Tuana, L Mosca, L Lombardi, ... Clinical cancer research 19 (12), 3247-3258, 2013 | 61 | 2013 |
| Development of a New Zirconia-Toughened Alumina: Promising Mechanical Properties and Absence of In Vitro Carcinogenicity G Maccauro, G Bianchino, S Sangiorgi, G Magnani, D Marotta, ... International journal of immunopathology and pharmacology 22 (3), 773-779, 2009 | 57 | 2009 |
| GSTM1 and NAT2 polymorphisms and colon, lung and bladder cancer risk: a case-control study A Zupa, A Sgambato, G Bianchino, G Improta, V Grieco, G La Torre, ... Anticancer research 29 (5), 1709-1714, 2009 | 46 | 2009 |
| Knockdown of miR-128a induces Lin28a expression and reverts myeloid differentiation blockage in acute myeloid leukemia L De Luca, S Trino, I Laurenzana, D Tagliaferri, G Falco, V Grieco, ... Cell death & disease 8 (6), e2849-e2849, 2017 | 44 | 2017 |
| Increased expression of cyclin E is associated with an increased resistance to doxorubicin in rat fibroblasts A Sgambato, A Camerini, G Pani, R Cangiano, B Faraglia, G Bianchino, ... British journal of cancer 88 (12), 1956-1962, 2003 | 37 | 2003 |
| Response to recombinant erythropoietin alpha, without the adjunct of granulocyte-colony stimulating factor, is associated with a longer survival in patients with transfusion … P Musto, O Villani, MC Martorelli, G Pietrantuono, R Guariglia, ... Leukemia research 34 (8), 981-985, 2010 | 36 | 2010 |
| Differential toxic effects of methyl tertiary butyl ether and tert-butanol on rat fibroblasts in vitro A Sgambato, I Iavicoli, B De Paola, G Bianchino, A Boninsegna, ... Toxicology and Industrial Health 25 (2), 141-151, 2009 | 25 | 2009 |
| Abnormal cell-clearance and accumulation of autophagic vesicles in lymphocytes from patients affected with Ataxia-Teleangiectasia R D'Assante, A Fusco, L Palamaro, E Polishchuk, R Polishchuk, ... Clinical immunology 175, 16-25, 2017 | 21 | 2017 |
| Modulation of CD20 antigen expression after rituximab treatment: a retrospective study in patients with chronic lymphocytic leukemia F D’Auria, R Guariglia, O Villani, G Mansueto, V Grieco, A Zonno, ... Clinical therapeutics 32 (11), 1911-1916, 2010 | 19 | 2010 |
| Myelodysplastic disorders carrying both isolated del(5q) and JAK2V617F mutation: concise review, with focus on lenalidomide therapy P Musto, V Simeon, R Guariglia, G Bianchino, V Grieco, F Nozza, ... OncoTargets and therapy, 1043-1050, 2014 | 18 | 2014 |
| Human skin-derived keratinocytes and fibroblasts co-cultured on 3D poly ε-caprolactone scaffold support in vitro HSC differentiation into T-lineage committed cells L Palamaro, V Guarino, G Scalia, D Antonini, L De Falco, G Bianchino, ... International immunology 25 (12), 703-714, 2013 | 18 | 2013 |
| Chronic lymphocytic leukemia after chronic myeloid leukemia in the same patient: two different genomic events and a common treatment? G D'Arena, M Gemei, L Luciano, F D'Auria, S Deaglio, T Statuto, ... Journal of clinical oncology: official journal of the American Society of …, 2012 | 15 | 2012 |
| Polymorphisms of the CYP1A1, CYP2E1 and XRCC1 genes and cancer risk in a Southern Italian population: a case–control study G Bianchino, A Cittadini, V Grieco, A Traficante, A Zupa, G Improta, ... Anticancer research 31 (4), 1359-1365, 2011 | 14 | 2011 |
| Low frequency of hCDC4 mutations in human primary ovarian cancer A Sgambato, V Masciullo, M Di Salvatore, P Valdivieso, G Bianchino, ... Gynecologic oncology 105 (2), 553-555, 2007 | 13 | 2007 |
| Role of the common γ chain in cell cycle progression of human malignant cell lines I Vigliano, L Palamaro, G Bianchino, A Fusco, L Vitiello, V Grieco, ... International immunology 24 (3), 159-167, 2012 | 10 | 2012 |
